We are live on
!
Find out more
CFA
Camarda Financial Advisors Portfolio holdings
AUM
$190M
1-Year Est. Return
48.71%
This Fund
S&P 500
This Quarter
Est. Return
+2.01%
1 Year Est. Return
+48.71%
3 Year Est. Return
+132.11%
5 Year Est. Return
+247.64%
10 Year Est. Return
+511.39%
AUM
$147M
AUM Growth
-$17.1M
(-10%)
Cap. Flow
-$19.1M
Cap. Flow
% of AUM
-13.01%
Top 10 Holdings %
Top 10 Hldgs %
31.4%
Holding
300
New
87
Increased
44
Reduced
79
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MSF
Morgan Stanley Emerging Mkts Fd
MSF
|
+$2.94M |
| 2 |
Invesco Preferred ETF
PGX
|
+$707K |
| 3 |
Coca-Cola
KO
|
+$522K |
| 4 |
Verizon
VZ
|
+$292K |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$135K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FEO
First Trust/abrdn Emerging Opportunity Fund
FEO
|
+$4.44M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$2.21M |
| 3 |
BlackRock Enhanced Equity Dividend Trust
BDJ
|
+$2.17M |
| 4 |
Invesco S&P MidCap 400 Pure Value ETF
RFV
|
+$1.15M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$918K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 10.78% |
| 2 | Technology | 9.25% |
| 3 | Communication Services | 7.05% |
| 4 | Industrials | 6.62% |
| 5 | Consumer Discretionary | 6.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Xylem
XYL
$27.8B
| $2K | ﹤0.01% |
+47
| New | +$2.38K |
|
227
Zoetis
ZTS
$32.3B
| $2K | ﹤0.01% |
+32
| New | +$1.63K |
|
228
Corpay
CPAY
$25.2B
| $2K | ﹤0.01% |
+12
| New | +$1.88K |
|
|
CERN
229
DELISTED
Cerner Corp
CERN
| $2K | ﹤0.01% |
+38
| New | +$2.02K |
|
|
KSU
230
DELISTED
Kansas City Southern
KSU
| $2K | ﹤0.01% |
+19
| New | +$1.68K |
|
|
ALXN
231
DELISTED
Alexion Pharmaceuticals
ALXN
| $2K | ﹤0.01% |
+19
| New | +$2.33K |
|
|
CELG
232
DELISTED
Celgene Corp
CELG
| $2K | ﹤0.01% |
+18
| New | +$2K |
|
233
Agilent Technologies
A
$39.5B
| $1K | ﹤0.01% |
+27
| New | +$1.23K |
|
234
Adobe
ADBE
$99.9B
| $1K | ﹤0.01% |
9
-55
| -86% | -$5.82K |
|
235
Ashland
ASH
$3.29B
| $1K | ﹤0.01% |
+22
| New | +$1.21K |
|
236
Boeing
BA
$185B
| $1K | ﹤0.01% |
8
-40
| -83% | -$5.84K |
|
237
Chipotle Mexican Grill
CMG
$47.5B
| $1K | ﹤0.01% |
+150
| New | +$1.18K |
|
238
Community Health Systems
CYH
$412M
| $1K | ﹤0.01% |
100
| – | – |
|
239
Edwards Lifesciences
EW
$51.1B
| $1K | ﹤0.01% |
+45
| New | +$1.46K |
|
240
McCormick & Company Non-Voting
MKC
$13.9B
| $1K | ﹤0.01% |
+20
| New | +$933 |
|
241
Northrop Grumman
NOC
$77.9B
| $1K | ﹤0.01% |
+4
| New | +$930 |
|
242
NXP Semiconductors
NXPI
$56.5B
| $1K | ﹤0.01% |
+15
| New | +$1.49K |
|
243
O'Reilly Automotive
ORLY
$73.3B
| $1K | ﹤0.01% |
+60
| New | +$1.1K |
|
244
Pentair
PNR
$10.7B
| $1K | ﹤0.01% |
15
| – | – |
|
245
Prothena Corp
PRTA
$435M
| $1K | ﹤0.01% |
12
| – | – |
|
246
PVH
PVH
$4.1B
| $1K | ﹤0.01% |
+10
| New | +$1.05K |
|
247
Roper Technologies
ROP
$38.8B
| $1K | ﹤0.01% |
+8
| New | +$1.43K |
|
248
Stryker
SYK
$131B
| $1K | ﹤0.01% |
+12
| New | +$1.38K |
|
249
Vertex Pharmaceuticals
VRTX
$119B
| $1K | ﹤0.01% |
+20
| New | +$1.63K |
|
250
Valvoline
VVV
$4.95B
| $1K | ﹤0.01% |
+28
| New | +$593 |
|
Similar funds
HCM
RCAP
WSL
BC
SCM
BCPWM
SF
PGDP
Camarda Financial Advisors's Q4 2016 Portfolio in Review
As of Q4 2016, Camarda Financial Advisors held 300 positions worth $147M, down 10% from $164M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Camarda Financial Advisors withdrew a net $19.1M in Q4 2016, closing 39 positions and reducing 79 holdings. Its most notable exit was First Trust/abrdn Emerging Opportunity Fund, an estimated $4.44M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 11% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Camarda Financial Advisors opened a new position in Morgan Stanley Emerging Mkts Fd worth $2.82M.
- Camarda Financial Advisors's largest Q4 2016 buy was Morgan Stanley Emerging Mkts Fd: 213,980 shares worth $2.82M.
- Camarda Financial Advisors added most to Invesco Preferred ETF in Q4 2016, an estimated $707K increase.
- Camarda Financial Advisors's biggest Q4 2016 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $2.21M.
- Camarda Financial Advisors fully exited First Trust/abrdn Emerging Opportunity Fund in Q4 2016, selling an estimated $4.44M.
- Camarda Financial Advisors's ten largest holdings make up 31% of its $147M portfolio in Q4 2016.
- Camarda Financial Advisors opened 87 new positions and closed 39 in Q4 2016.
- Camarda Financial Advisors's portfolio value fell 10% quarter-over-quarter to $147M.
Based on Camarda Financial Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.